Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04044391 · ClinicalTrials.gov registry record
Use of Magnetocardiography in Evaluation of Patients Going for Cardiac Catheterization
A clinical trial, sponsored by Genetesis.
- Terminated
- Registry status
- 101
- Enrollment target
NCT04044391 is a clinical trial that was terminated before completion, run by Genetesis. The registered enrollment target is 101 participants.
The verdict
NCT04044391 was terminated before completion, sponsored by Genetesis.
- TERMINATED
- Registry status
- 101 participants
- Enrollment target
Study Summary
This is a multicenter, prospective trial to measure the test performance characteristics of the Magnetocardiography (MCG) CardioFlux cardiac diagnostic system in detecting clinically significant coronary artery obstruction in patients with symptoms of suspected acute coronary syndrome or who present with a failed stress test with the intention of treat with cardiac catheterization.
Interventions
- DIAGNOSTIC_TEST CardioFlux Magnetocardiograph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2020-05-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04044391
The ClinicalTrials.gov registry entry for NCT04044391 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genetesis, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CardioFlux Magnetocardiograph is the first listed.
NCT04044391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04044391 about?
NCT04044391 is a clinical study titled "Use of Magnetocardiography in Evaluation of Patients Going for Cardiac Catheterization". This is a multicenter, prospective trial to measure the test performance characteristics of the Magnetocardiography (MCG) CardioFlux cardiac diagnostic system in detecting clinically significant coronary artery obstruction in patients with symptoms of suspected acute coronary syndrome or who present...
What is the current status of trial NCT04044391?
This trial is currently terminated. The enrollment target is 101 participants. The study started on 2019-05-15. Estimated completion is 2020-05-04.
What interventions are being tested in trial NCT04044391?
The interventions under investigation include: CardioFlux Magnetocardiograph (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04044391?
This trial is sponsored by Genetesis, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.